Cargando…
Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
BACKGROUND: The mammalian target of rapamycin (mTOR) plays a key role in cellular growth and homeostasis. The purpose of our present study is to investigate the expression of activated mTOR (p-mTOR) in gastric cancer patients, their prognostic significance and the inhibition effect of RAD001 on tumo...
Autores principales: | Xu, Da-zhi, Geng, Qi-rong, Tian, Ying, Cai, Mu-yan, Fang, Xin-juan, Zhan, You-qing, Zhou, Zhi-wei, Li, Wei, Chen, Ying-bo, Sun, Xiao-wei, Guan, Yuan-xiang, Li , Yuan-fang, Lin, Tong-yu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958947/ https://www.ncbi.nlm.nih.gov/pubmed/20929525 http://dx.doi.org/10.1186/1471-2407-10-536 |
Ejemplares similares
-
Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014) -
Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation
por: Tao, Yan-Fang, et al.
Publicado: (2017) -
Tramadol Pretreatment Enhances Ketamine-Induced Antidepressant Effects and Increases Mammalian Target of Rapamycin in Rat Hippocampus and Prefrontal Cortex
por: Yang, Chun, et al.
Publicado: (2012) -
Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018) -
Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells
por: Dai, Zhi-Jun, et al.
Publicado: (2013)